RxDoctor Payments DataLook up a doctor →

Bradley Freilich, MD

Gastroenterology · Kansas City, MONPI 1659424810

Payments from drug & device makers

$4,480,890in general payments, 2019–2025

Across 1,344 payments — averaging $3334.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intercept Pharmaceuticals, Inc.$1.4M
  • Madrigal Pharmaceuticals$826K
  • Eli Lilly$365K
  • Gilead$331K
  • Genentech, Inc.$307K
  • Seqirus USA Inc$306K
  • plus $971K from 53 others
$5,444in research payments, 2019–2025

Across 3 payments — averaging $1814.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$5K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intercept Pharmaceuticals, Inc.183$1,373,461
Madrigal Pharmaceuticals77$826,325
Eli Lilly4$365,338
Gilead85$330,676
Genentech, Inc.21$307,289
Seqirus USA Inc108$306,467
Bausch Health US, LLC141$244,990
Intercept Pharma Europe Ltd.23$153,077
Tanabe Pharma America, Inc.124$148,686
Exelixis Inc.30$118,640
Mitsubishi Tanabe Pharma Development America, Inc.6$102,460
Boehringer Ingelheim International GmbH76$81,123
Novo Nordisk AS150$28,906
Corcept Therapeutics5$14,000
Eisai Inc.2$13,947
EMD Serono, Inc.4$12,562
Endogastric Solutions, Inc10$12,444
Shire North American Group Inc1$10,891
AbbVie(2 entities)80$7,857
Novocure Inc.1$6,000
E.r. Squibb & Sons, L.L.C.1$4,500
Novo Nordisk18$2,901
Dova Pharmaceuticals7$2,767
Ardelyx, Inc.8$1,238
Apollo Endosurgery US Inc6$840
Pfizer36$531
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC24$375
Johnson & Johnson20$360
Takeda Pharmaceuticals U.S.A., Inc.16$318
Bristol Myers Squibb15$224
Histosonics, Inc.1$222
Lilly USA, LLC6$161
Ipsen Biopharmaceuticals, Inc3$147
Janssen Scientific Affairs, LLC1$102
Amgen5$102
Sanofi4$101
Covidien LP1$90
Celltrion USA Inc.5$86
Merck4$67
Ironwood Pharmaceuticals, Inc4$51
Iterative Scopes, Inc.1$47
Boehringer Ingelheim1$47
Braintree Laboratories, Inc.3$45
Nestle Healthcare Nutrition Inc.2$43
Bayer2$42
Capsovision, Inc.1$42
Medtronic3$40
UCB, Inc.2$34
Ferring Pharmaceuticals Inc.2$34
Micro-tech Endoscopy USA, Inc.2$27
Digestive Care, Inc.1$26
Alnylam Pharmaceuticals Inc.1$25
Regeneron Healthcare Solutions, Inc.1$23
Aimmune Therapeutics, Inc.1$22
Rhythm Pharmaceuticals, Inc.1$18
Mallinckrodt Hospital Products Inc.1$17
AstraZeneca1$14
Dynavax Technologies Corporation1$13
Currax Pharmaceuticals LLC1$11

How this compares

$4,480,890 in reported general payments places this provider in the 95th percentile of 374 gastroenterology providers in Missouri.

See all gastroenterology providers in Missouri →

Medicare billing

Part B allowed, 2024
$70,322
Medicare patients
295
Services billed
530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Kansas City

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →